Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis.

Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis.
复制标题

DOI:
10.1186/s12864-015-2270-1
复制
发表时间:
2015-12-16
期刊:
影响因子:
4.4
通讯作者:
Broeckel U
Broeckel U
中科院分区:
生物学2区
文献类型:
--
作者:
Li W;Turner A;Aggarwal P;Matter A;Storvick E;Arnett DK;Broeckel U

文献摘要

被引文献

相似文献

全转录组测序(RNA-seq)是分析全转录组基因表达的有效方法。然而,RNA-SEQ有一些限制,例如,需要大量的输入RNA,以及短读写的非特异性映射导致的复杂性。Ion AmpliSeq™转录人类基因表达试剂盒(AmpliSeq)是生命科技公司最近推出的一种全转录组、靶向基因定量试剂盒,以克服RNASeq的这些局限性。为了评估这种新方法的性能,我们使用两个成熟的下一代测序平台(Illumina HiSeq和Ion Torrent Proton)对AmpliSeq和RNA-Seq进行了全面的比较。我们分析了标准参考RNA样本和从人诱导多能干细胞来源的心肌细胞(hiPSC-CMS)获得的RNA样本。使用已公布的两个标准核糖核酸参考样本的数据,当比较AmpliSeq与Illumina HiSeq(Pearson‘s r = 0.92)和Ion Torrent Proton(Pearson’s r = 0.92)时,我们观察到所有基因的log2倍变化具有很强的一致性。我们使用ROC、Matthew‘s相关系数和RMSD来确定总体性能特征。所有三种统计方法都表明AmpliSeq是一种用于差异基因表达分析的高度准确的方法。此外,对于丰度较高的基因,AmpliSeq的性能优于两种RNA-SEQ方法。在分析四个密切相关的HiPSC-CM系时,我们表明AmpliSeq和RNA-seq都捕获了类似的全球基因表达模式,与已知的变异来源一致。我们的研究表明AmpliSeq在RNA-seq的限制区域更适合于基因表达的定量分析。因此,AmpliSeq是一种非常敏感且经济高效的方法,可用于超大规模的基因表达分析和高准确度的mRNA标记筛选。本文的在线版本(doi:10.1186/s12864-0152270-1)包含补充材料,授权用户可以使用。
Whole transcriptome sequencing (RNA-seq) represents a powerful approach for whole transcriptome gene expression analysis. However, RNA-seq carries a few limitations, e.g., the requirement of a significant amount of input RNA and complications led by non-specific mapping of short reads. The Ion AmpliSeq™ Transcriptome Human Gene Expression Kit (AmpliSeq) was recently introduced by Life Technologies as a whole-transcriptome, targeted gene quantification kit to overcome these limitations of RNA-seq. To assess the performance of this new methodology, we performed a comprehensive comparison of AmpliSeq with RNA-seq using two well-established next-generation sequencing platforms (Illumina HiSeq and Ion Torrent Proton). We analyzed standard reference RNA samples and RNA samples obtained from human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). Using published data from two standard RNA reference samples, we observed a strong concordance of log2 fold change for all genes when comparing AmpliSeq to Illumina HiSeq (Pearson’s r = 0.92) and Ion Torrent Proton (Pearson’s r = 0.92). We used ROC, Matthew’s correlation coefficient and RMSD to determine the overall performance characteristics. All three statistical methods demonstrate AmpliSeq as a highly accurate method for differential gene expression analysis. Additionally, for genes with high abundance, AmpliSeq outperforms the two RNA-seq methods. When analyzing four closely related hiPSC-CM lines, we show that both AmpliSeq and RNA-seq capture similar global gene expression patterns consistent with known sources of variations. Our study indicates that AmpliSeq excels in the limiting areas of RNA-seq for gene expression quantification analysis. Thus, AmpliSeq stands as a very sensitive and cost-effective approach for very large scale gene expression analysis and mRNA marker screening with high accuracy. The online version of this article (doi:10.1186/s12864-015-2270-1) contains supplementary material, which is available to authorized users.